Intrathecal 131I-labeled antitenascin monoclonal antibody 81C6 treatment of patients with leptomeningeal neoplasms or primary brain tumor resection cavities with subarachnoid communication: phase I trial results (Q77557098)
Jump to navigation
Jump to search
scientific article published on 01 June 1996
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Intrathecal 131I-labeled antitenascin monoclonal antibody 81C6 treatment of patients with leptomeningeal neoplasms or primary brain tumor resection cavities with subarachnoid communication: phase I trial results |
scientific article published on 01 June 1996 |
Statements
Intrathecal 131I-labeled antitenascin monoclonal antibody 81C6 treatment of patients with leptomeningeal neoplasms or primary brain tumor resection cavities with subarachnoid communication: phase I trial results (English)
Brown MT
Friedman AH
Friedman HS
McLendon RE
Reiman R
Felsberg GJ
Tien RD
Bigner SH
Zalutsky MR
Zhao XG
Wikstrand CJ
Pegram CN
Herndon JE 2nd
Vick NA
Paleologos N
Fredericks RK
Schold SC Jr